The Drug Rediscovery Protocol (DRUP Trial)

NCT02925234 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

1550

Enrollment

OTHER

Sponsor class

Conditions

Cancer
Tumors
Neoplasm
Neoplasia

Interventions

DRUG: Panitumumab
DRUG: Olaparib
DRUG: Dabrafenib
DRUG: Nilotinib
DRUG: Trametinib
DRUG: Erlotinib
DRUG: Trastuzumab and Pertuzumab (combination treatment)
DRUG: Vemurafenib and Cobimetinib (combination treatment)
DRUG: Vismodegib
DRUG: Regorafenib
DRUG: Nivolumab
DRUG: Afatinib
DRUG: Dabrafenib and trametinib
DRUG: Ribociclib
DRUG: Lenvatinib
DRUG: Pembrolizumab
DRUG: Durvalumab
DRUG: Rucaparib
DRUG: Axitinib
DRUG: Palbociclib

Sponsor

The Netherlands Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]